Table of Contents

December 01, 2022; Volume 89,Issue 12

From the Editor

The Clinical Picture

  • Asymptomatic granules on the buccal mucosa
    Keiichi Ohta, DDS and Hitoshi Yoshimura, DDS, PhD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 676-677; DOI: https://doi.org/10.3949/ccjm.89a.22025

    A healthy 35-year-old man presented with multiple small, white-yellow papules.

Commentary

  • Ignore e-cigarettes at your patient’s peril
    Vania Modesto-Lowe, MD, MPH, Lakshit Jain, MD and Roberto León-Barriera, MD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 679-682; DOI: https://doi.org/10.3949/ccjm.89a.22006

    As patients are already using these products, rather than dismiss the use of e-cigarettes, clinicians should provide accurate information to help patients make the best choices for their health.

  • Should ‘daily labs’ be a quality priority in hospital medicine?
    Caleb J. Murphy, MD, MBA and Andrew W. Schram, MD, MBA
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 685-688; DOI: https://doi.org/10.3949/ccjm.89a.22036

    Evidence shows that unnecessary daily testing is only a minor contributor to anemia and healthcare costs for most inpatients. The effect on patient experience has not been definitively established.

Editorial

1-Minute Consult

Guidelines to Practice

Symptoms to Diagnosis

  • A 60-year-old man with prostate cancer and embolic strokes
    Neha K. Reddy, MD, MA, Christian Scherer, DO, Samuel Kessel, MD, MBA and Alejandro Moreno, MBBS, MPH, JD, MACP
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 705-711; DOI: https://doi.org/10.3949/ccjm.89a.21079

    Step-by-step evaluation of a patient with stage IV prostate cancer and embolic stroke, but no history of heart valve disease, arrhythmia, or coagulopathy.

Review

  • On the horizon: Extracorporeal carbon dioxide removal
    On the horizon: Extracorporeal carbon dioxide removal
    Justin Hanks, DO, Steven Fox, MD, Omar Mehkri, MD, Laura W. Lund, PhD, Tracey Dill, RRT, Abhijit Duggal, MD, MPH, MSc and Sudhir Krishnan, MD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 712-718; DOI: https://doi.org/10.3949/ccjm.89a.21084

    Extracorporeal carbon dioxide removal to treat hypercapnic respiratory failure has been studied in acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and other conditions.

  • Is your patient at risk for NAFLD?
    Patress Ann Persons, MD, FACP, Sophie Bersoux, MD, MPH, FACP and Mary Helen Whited, MD, FACP
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 719-727; DOI: https://doi.org/10.3949/ccjm.89a.22005
Back to top

In this issue

Jump to